Skip to main content
Clinical Trials/KCT0002704
KCT0002704
Recruiting
未知

A Study on Depression Related Indicators of Healthy Women

Korea Institute of Oriental Medicine0 sites50 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Mental and behavioral disorders
Sponsor
Korea Institute of Oriental Medicine
Enrollment
50
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Observational Study
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Women aged 20 to 65 years
  • 2\) The Korean Hamilton Depression Rating Scale score is less than 7
  • 3\) Those who can make sufficient communication and questionnaire
  • 4\) Decide on voluntary participation and sign the written agreement

Exclusion Criteria

  • 1\) People with a medical condition that may affect the degree of depression (eg, myocardial infarction, brain tumor, multiple sclerosis, hyperthyroidism, hyperparathyroidism, Addison's disease, Cushing's disease, rheumatoid arthritis, Vascular disease, epilepsy, etc.)
  • 2\) Those who have undergone medical surgery or treatment within 1 month of the start of clinical research
  • 3\) Those who have had acute and chronic infectious diseases for the last 2 weeks
  • 4\) Those who had excessive diet control for disease\-related or weight control purposes within one week of the start of clinical studies
  • 5\) Those who are taking periodical medicines by internal medicine, surgery, psychiatric diagnosis at the time of starting the clinical study, and those who are thought to be able to influence the autonomic nervous system and depressive symptom manifestations (eg anxiolytics, antidepressants, L\-dopa, Digitalis, bromide, cyclosporin, disulfiram, isoniazid, yohimbine, etc.)
  • 6\) Those who have been diagnosed with medical or psychiatric disorders and have not been informed about clinical symptoms or biochemical indicators
  • 7\) Those with chronic diseases that are not well controlled by appropriate treatment (chronic active hepatitis, hypertension, diabetes, etc.)
  • 8\) Those who are treated with liver cancer or liver cirrhosis, chronic renal failure, congestive heart failure, etc.
  • 9\) Those who are pregnant or are pregnant or are lactating
  • 10\) AST or ALT exceeds 2 times the upper limit of the reference range, or Total Bilirubin exceeds 2 times the upper limit of the reference range

Outcomes

Primary Outcomes

Not specified

Similar Trials